Dora Pinto
Impact in
- Infectious Diseases top 0.05%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 20
-
- Immunotherapy and Immune Responses 5
- T-cell and B-cell Immunology 3
- Co-authors
- Federica Sallusto (3 shared papers)Antonio Lanzavecchia (3 shared papers)David Jarrossay (2 shared papers)Erica Montani (1 shared paper)Guido Garavaglia (1 shared paper)Martin Bolli (1 shared paper)Davide Corti (1 shared paper)Christina E. Zielinski (1 shared paper)
- Journals
- Nature (8 papers)Science (6 papers)Cell (4 papers)Infection and Immunity (2 papers)Blood (1 paper)
- Partner nations
- United StatesSwitzerlandBelgium
In The Last Decade
Dora Pinto
30 papers receiving 9.6k citations
Dora Pinto's Hit Papers
Peers
Comparison fields: 5 of 83
- Infectious Diseases 8.0k
- Modeling and Simulation 84
- Immunology 200
- Virology 47
- Biotechnology 29
Countries citing papers authored by Dora Pinto
This map shows the geographic impact of Dora Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Pinto more than expected).
Fields of papers citing papers by Dora Pinto
This network shows the impact of papers produced by Dora Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Pinto. The network helps show where Dora Pinto may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Pinto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody Hit paper breakdown → | 2020 | 1469 |
| 2 | Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology Hit paper breakdown → | 2020 | 1059 |
| 3 | SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion Hit paper breakdown → | 2021 | 1003 |
| 4 | Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Hit paper breakdown → | 2021 | 884 |
| 5 | Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies Hit paper breakdown → | 2021 | 726 |
| 6 | N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 Hit paper breakdown → | 2021 | 688 |
| 7 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 8 | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity Hit paper breakdown → | 2021 | 484 |
| 9 | 2020 | 401 | |
| 10 | SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape Hit paper breakdown → | 2021 | 377 |
| 11 | SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern Hit paper breakdown → | 2021 | 336 |
| 12 | 2021 | 296 | |
| 13 | 2021 | 205 | |
| 14 | 2021 | 184 | |
| 15 | Imprinted antibody responses against SARS-CoV-2 Omicron sublineages Hit paper breakdown → | 2022 | 176 |
| 16 | 2022 | 138 | |
| 17 | 2013 | 121 | |
| 18 | 2022 | 117 | |
| 19 | Neutralization, effector function and immune imprinting of Omicron variants Hit paper breakdown → | 2023 | 105 |
| 20 | 2011 | 93 |
About Dora Pinto
Dora Pinto is a scholar working on Infectious Diseases, Immunology, Virology, Oncology and Nuclear Energy and Engineering, having authored 30 papers that have together received 9.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (20 papers), Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (3 papers), Chemokine receptors and signaling (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (8.0k citations), Modeling and Simulation (84 citations), Immunology (200 citations), Virology (47 citations) and Biotechnology (29 citations). Dora Pinto has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Federica Sallusto, Antonio Lanzavecchia, David Jarrossay, Erica Montani, Guido Garavaglia, Martin Bolli, Davide Corti, Christina E. Zielinski, Federico Mele and Donatella R. M. Negri. Their work appears in journals such as Nature, Science, Cell, Infection and Immunity and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.